Ministry of Public Health Partners with Bayer to Advance the Medical Investment Hub
Article excerpt
Dr. Somruek Chungsaman, Permanent Secretary of the Ministry of Public Health, said that the Ministry places importance on using technology and innovation to improve the efficiency of the health service system, particularly early screening and diagnosis, the development of the patient referral system, and greater access to quality medical services. The Ministry also promotes clinical research and the use of real-world evidence to support health policy development. "The Ministry of Public Health is committed to promoting the application of AI technology in retinal disease screening, especially for at-risk diabetic patients. We are also strengthening the capacity of healthcare facilities and the referral system so that screening, diagnosis and treatment are effectively connected, in order to increase access to services, reduce the risk of vision loss, and improve people's quality of life." The cooperation also covers proposals to promote access to innovative medicines for patients with retinal diseases and prostate cancer, as well as studies on innovations to prevent recurrent stroke, together with investment in clinical research and the development of real-world evidence. These efforts aim to support the development of the health service system and strengthen Thailand's potential to become a hub for medical research and innovation under the Medical Investment Hub policy...
Keep reading with a free account
The rest of this article, and every signal for Bayer, is in your free account.
Extracted from this sentence
Through our partnership with the Ministry of Public Health, we want to expand clinical research, help bring innovative treatments to patients earlier and further strengthen local research capabilities.
